Your browser doesn't support javascript.
loading
Galectin-3 is elevated in CSF and is associated with Aß deposits and tau aggregates in brain tissue in Alzheimer's disease.
Boza-Serrano, Antonio; Vrillon, Agathe; Minta, Karolina; Paulus, Agnes; Camprubí-Ferrer, Lluís; Garcia, Megg; Andreasson, Ulf; Antonell, Anna; Wennström, Malin; Gouras, Gunnar; Dumurgier, Julien; Cognat, Emmanuel; Molina-Porcel, Laura; Balasa, Mircea; Vitorica, Javier; Sánchez-Valle, Raquel; Paquet, Claire; Venero, Jose Luis; Blennow, Kaj; Deierborg, Tomas.
Affiliation
  • Boza-Serrano A; Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, 22184, Lund, Sweden. aboza@us.es.
  • Vrillon A; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. aboza@us.es.
  • Minta K; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Seville and IBIS (Institute of Biomedicine of Seville), University Hospital Virgen del Rocio, CSIC, Seville, Spain. aboza@us.es.
  • Paulus A; Université Paris Cité, Inserm U1144, Paris, France. agathe.vrillon@aphp.fr.
  • Camprubí-Ferrer L; Center of Cognitive Neurology, Université Paris Cité, Lariboisière Fernand-Widal Hospital, APHP, Paris, France. agathe.vrillon@aphp.fr.
  • Garcia M; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Andreasson U; Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, 22184, Lund, Sweden.
  • Antonell A; Medical Microspectroscopy Laboratory, Department of Experimental Medical Science, Lund University, 22184, Lund, Sweden.
  • Wennström M; Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, 22184, Lund, Sweden.
  • Gouras G; Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, 22184, Lund, Sweden.
  • Dumurgier J; Experimental Dementia Laboratory, Department of Experimental Medical Sciences, Lund University, 221 84, Lund, Sweden.
  • Cognat E; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Molina-Porcel L; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Balasa M; Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
  • Vitorica J; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
  • Sánchez-Valle R; Experimental Dementia Laboratory, Department of Experimental Medical Sciences, Lund University, 221 84, Lund, Sweden.
  • Paquet C; Université Paris Cité, Inserm U1144, Paris, France.
  • Venero JL; Center of Cognitive Neurology, Université Paris Cité, Lariboisière Fernand-Widal Hospital, APHP, Paris, France.
  • Blennow K; Université Paris Cité, Inserm U1144, Paris, France.
  • Deierborg T; Center of Cognitive Neurology, Université Paris Cité, Lariboisière Fernand-Widal Hospital, APHP, Paris, France.
Acta Neuropathol ; 144(5): 843-859, 2022 11.
Article in En | MEDLINE | ID: mdl-35895141

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Acta Neuropathol Year: 2022 Document type: Article Affiliation country: Sweden Country of publication: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Acta Neuropathol Year: 2022 Document type: Article Affiliation country: Sweden Country of publication: Germany